A major advance in cancer research is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This vital tumor protector protein is frequently inactivated in several kinds of tumors, resulting https://directmysocial.com/story6742001/nanobodies-restore-tumor-suppressor-p53-the-potential-approach-for-tumor-management